Last reviewed · How we verify
NCT04398381: ProSyDICU
Prognosis of SRD Patients in the ICU
trial in Systemic Rheumatic Diseases in 525 participants. Completed in 30 June 2019.
1 June 2019
Quick facts
| Lead sponsor | University Hospital, Montpellier |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 525 |
| Start date | 1 March 2017 |
| Primary completion | 1 June 2019 |
| Estimated completion | 30 June 2019 |
| Sites | 1 location across France |
Conditions studied
- Systemic Rheumatic Diseases — all drugs for Systemic Rheumatic Diseases →
- Intensive Care Unit — all drugs for Intensive Care Unit →
- Corticosteroids — all drugs for Corticosteroids →
Sponsor
University Hospital, Montpellier
Who can join
Adults 18 to 100, any sex, with Systemic Rheumatic Diseases or Intensive Care Unit. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Critically ill systemic rheumatic disease (SRD) patients have benefited from better provision of rheumatic and critical care in recent years. Recent comprehensive data regarding in-hospital mortality and most importantly long-term outcome are scarce. The aim of this study is to assess short and long-term outcome of patients with SRD admitted to the ICU in a retrospective cohort study (2006 - 2016).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Interstitial Lung Disease Worsens Short- and Long-Term Outcomes of Systemic Rheumatic Disease Patients Admitted to the ICU: A Multicenter Study.
Banuls L, Vanoverschelde J, Garnier F, Amalric M, et al · · 2021 · cited 4× · PMID 33802364 · DOI 10.3390/jcm10051037
Verify or expand the search:
- PubMed search for NCT04398381
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other University Hospital, Montpellier trials
Trials by the same sponsor.
- NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
- NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
- NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
- NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
- NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04398381 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
- Last refreshed: 28 May 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04398381.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing